Chemistry:N6-Methyladenosine

From HandWiki
Short description: Modification in mRNA, DNA


N6-Methyladenosine
N6-Methyladenosine.svg
Names
IUPAC name
N6-Methyladenosine
Systematic IUPAC name
(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-[6-(methylamino)-9H-purin-9-yl]oxolane-2,3-diol
Other names
m6A
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
UNII
Properties
C11H15N5O4
Molar mass 281.272 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Tracking categories (test):

N6-Methyladenosine (m6A) was originally identified and partially characterised in the 1970s,[1][2][3][4] and is an abundant modification in mRNA and DNA.[5] It is found within some viruses,[4][3][6][7] and most eukaryotes including mammals,[2][1][8][9] insects,[10] plants[11][12][13] and yeast.[14][15] It is also found in tRNA, rRNA, and small nuclear RNA (snRNA) as well as several long non-coding RNA, such as Xist.[16][17]

The methylation of adenosine is directed by a large m6A methyltransferase complex containing METTL3, which is the subunit that binds S-adenosyl-L-methionine (SAM).[18] In vitro, this methyltransferase complex preferentially methylates RNA oligonucleotides containing GGACU[19] and a similar preference was identified in vivo in mapped m6A sites in Rous sarcoma virus genomic RNA[20] and in bovine prolactin mRNA.[21] More recent studies have characterized other key components of the m6A methyltransferase complex in mammals, including METTL14,[22][23] Wilms tumor 1 associated protein (WTAP),[22][24] VIRMA[25] and METTL5.[26] Following a 2010 speculation of m6A in mRNA being dynamic and reversible,[27] the discovery of the first m6A demethylase, fat mass and obesity-associated protein (FTO) in 2011[28] confirmed this hypothesis and revitalized the interests in the study of m6A. A second m6A demethylase alkB homolog 5 (ALKBH5) was later discovered as well.[29]

The biological functions of m6A are mediated through a group of RNA binding proteins that specifically recognize the methylated adenosine on RNA. These binding proteins are named m6A readers. The YT521-B homology (YTH) domain family of proteins (YTHDF1, YTHDF2, YTHDF3 and YTHDC1) have been characterized as direct m6A readers and have a conserved m6A-binding pocket.[17][30][31][32][33] Insulin-like growth factor-2 mRNA-binding proteins 1, 2, and 3 (IGF2BP1–3) are reported as a novel class of m6A readers.[34] IGF2BPs use K homology (KH) domains to selectively recognize m6A-containing RNAs and promote their translation and stability.[34] These m6A readers, together with m6A methyltransferases (writers) and demethylases (erasers), establish a complex mechanism of m6A regulation in which writers and erasers determine the distributions of m6A on RNA, whereas readers mediate m6A-dependent functions. m6A has also been shown to mediate a structural switch termed m6A switch.[35]

The specificity of m6A installation on mRNA is controlled by exon architecture and exon junction complexes. Exon junction complexes suppress m6A methylation near exon-exon junctions by packaging nearby RNA and protecting it from methylation by the m6A methyltransferase complex. m6A regions in long internal and terminal exons, away from exon-exon junctions and exon junction complexes, escape suppression and can be methylated by the methyltransferase complex. [36]

Species distribution

Yeast

In budding yeast (Saccharomyces cerevisiae), the expression of the homologue of METTL3, IME4, is induced in diploid cells in response to nitrogen and fermentable carbon source starvation and is required for mRNA methylation and the initiation of correct meiosis and sporulation.[14][15] mRNAs of IME1 and IME2, key early regulators of meiosis, are known to be targets for methylation, as are transcripts of IME4 itself.[15]

Plants

In plants, the majority of the m6A is found within 150 nucleotides before the start of the poly(A) tail.[37]

Mutations of MTA, the Arabidopsis thaliana homologue of METTL3, results in embryo arrest at the globular stage. A >90% reduction of m6A levels in mature plants leads to dramatically altered growth patterns and floral homeotic abnormalities.[37]

Mammals

Mapping of m6A in human and mouse RNA has identified over 18,000 m6A sites in the transcripts of more than 7,000 human genes with a consensus sequence of [G/A/U][G>A]m6AC[U>A/C][16][17][38] consistent with the previously identified motif. The localization of individual m6A sites in many mRNAs is highly similar between human and mouse,[16][17] and transcriptome-wide analysis reveals that m6A is found in regions of high evolutionary conservation.[16] m6A is found within long internal exons and is preferentially enriched within 3' UTRs and around stop codons. m6A within 3' UTRs is also associated with the presence of microRNA binding sites; roughly 2/3 of the mRNAs which contain an m6A site within their 3' UTR also have at least one microRNA binding site.[16] By integrating all m6A sequencing data, a novel database called RMBase has identified and provided ~200,000 sites in the human and mouse genomes corresponding to N6-Methyladenosines (m6A) in RNA.[38]

Precise m6A mapping by m6A-CLIP/IP [39] (briefly m6A-CLIP) revealed that a majority of m6A locates in the last exon of mRNAs in multiple tissues/cultured cells of mouse and human,[39] and the m6A enrichment around stop codons is a coincidence that many stop codons locate round the start of last exons where m6A is truly enriched.[39] The major presence of m6A in last exon (>=70%) allows the potential for 3'UTR regulation, including alternative polyadenylation.[39] The study combining m6A-CLIP with rigorous cell fractionation biochemistry reveals that m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover.[40][41]

m6A is susceptible to dynamic regulation both throughout development and in response to cellular stimuli. Analysis of m6A in mouse brain RNA reveals that m6A levels are low during embryonic development and increase dramatically by adulthood.[16] In mESCs and during mouse development, FTO has been shown to mediated LINE1 RNA m6A demethylation and consequently affect local chromatin state and nearby gene transcription.[42] Additionally, silencing the m6A methyltransferase significantly affects gene expression and alternative RNA splicing patterns, resulting in modulation of the p53 (also known as TP53) signalling pathway and apoptosis.[17]

m6A is also found on the RNA components of R-loops in human cells, where it is involved in regulation of stability of RNA:DNA hybrids.[43]

The importance of m6A methylation for physiological processes was recently demonstrated. Inhibition of m6A methylation via pharmacological inhibition of cellular methylations or more specifically by siRNA-mediated silencing of the m6A methylase Mettl3 led to the elongation of the circadian period. In contrast, overexpression of Mettl3 led to a shorter period. The mammalian circadian clock, composed of a transcription feedback loop tightly regulated to oscillate with a period of about 24 hours, is therefore extremely sensitive to perturbations in m6A-dependent RNA processing, likely due to the presence of m6A sites within clock gene transcripts.[44][45] The effects of global methylation inhibition on the circadian period in mouse cells can be prevented by ectopic expression of an enzyme from the bacterial methyl metabolism. Mouse cells expressing this bacterial protein were resistant to pharmacological inhibition of methyl metabolism, showing no decrease in mRNA m6A methylation or protein methylation.[46]

Clinical significance

Considering the versatile functions of m6A in various physiological processes, it is thus not surprising to find links between m6A and numerous human diseases; many originated from mutations or single nucleotide polymorphisms (SNPs) of cognate factors of m6A. The linkages between m6A and numerous cancer types have been indicated in reports that include stomach cancer, prostate cancer, breast cancer, pancreatic cancer, kidney cancer, mesothelioma, sarcoma, and leukaemia.[47][48][49][50][51][52][53][54][55][56][57][58] The impacts of m6A on cancer cell proliferation might be much more profound with more data emerging. The depletion of METTL3 is known to cause apoptosis of cancer cells and reduce invasiveness of cancer cells,[59][60] while the activation of ALKBH5 by hypoxia was shown to cause cancer stem cell enrichment.[61] m6A has also been indicated in the regulation of energy homeostasis and obesity, as FTO is a key regulatory gene for energy metabolism and obesity. SNPs of FTO have been shown to associate with body mass index in human populations and occurrence of obesity and diabetes.[62][63][64][65][66] The influence of FTO on pre-adipocyte differentiation has been suggested.[67][68][69] The connection between m6A and neuronal disorders has also been studied. For instance, neurodegenerative diseases may be affected by m6A as the cognate dopamine signalling was shown to be dependent on FTO and correct m6A methylation on key signalling transcripts.[70] The mutations in HNRNPA2B1, a potential reader of m6A, have been known to cause neurodegeneration.[71] The IGF2BP1–3, a novel class of m6A reader, has oncogenic functions. IGF2BP1–3 knockdown or knockout decreased MYC protein expression, cell proliferation and colony formation in human cancer cell lines.[34] The ZC3H13, a member of the m6A methyltransferase complex, markedly inhibited colorectal cancer cells growth when knocked down.[72]

Additionally, m6A has been reported to impact viral infections. Many RNA viruses including SV40, adenovirus, herpes virus, Rous sarcoma virus, and influenza virus have been known to contain internal m6A methylation on virus genomic RNA.[73] Several more recent studies have revealed that m6A regulators govern the efficiency of infection and replication of RNA viruses such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and Zika virus (ZIKV).[74][75][76][77][78] These results suggest m6A and its cognate factors play crucial roles in regulating virus life cycles and host-viral interactions.

In bacteria

M6A methylation is also widespread in bacteria, where it can be introduced by methylases belonging to restriction/modification systems, or by orphan methylases. In the latter case, for instance in Caulobacter crescentus, m6A has a transcriptional modulatory effect.

References

  1. ↑ 1.0 1.1 "Modified nucleosides and bizarre 5'-termini in mouse myeloma mRNA". Nature 255 (5503): 28–33. May 1975. doi:10.1038/255028a0. PMID 1128665. Bibcode: 1975Natur.255...28A. 
  2. ↑ 2.0 2.1 "Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells". Proceedings of the National Academy of Sciences of the United States of America 71 (10): 3971–3975. October 1974. doi:10.1073/pnas.71.10.3971. PMID 4372599. Bibcode: 1974PNAS...71.3971D. 
  3. ↑ 3.0 3.1 "Methylation of nuclear simian virus 40 RNAs". Journal of Virology 32 (1): 52–60. October 1979. doi:10.1128/JVI.32.1.52-60.1979. PMID 232187. 
  4. ↑ 4.0 4.1 "Localization of N6-methyladenosine in the Rous sarcoma virus genome". Journal of Molecular Biology 113 (1): 165–179. June 1977. doi:10.1016/0022-2836(77)90047-X. PMID 196091. 
  5. ↑ "N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate". Stem Cells International 2018: 3256524. 2018. doi:10.1155/2018/3256524. PMID 30405719. 
  6. ↑ "Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication". Cell Host & Microbe 22 (3): 377–386.e5. September 2017. doi:10.1016/j.chom.2017.08.004. PMID 28910636. 
  7. ↑ "N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection" (in English). Cell Host & Microbe 20 (5): 654–665. November 2016. doi:10.1016/j.chom.2016.09.015. PMID 27773535. 
  8. ↑ "5'-Terminal and internal methylated nucleotide sequences in HeLa cell mRNA". Biochemistry 15 (2): 397–401. January 1976. doi:10.1021/bi00647a024. PMID 174715. 
  9. ↑ "The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5' terminus". Cell 4 (4): 387–394. April 1975. doi:10.1016/0092-8674(75)90159-2. PMID 1168101. 
  10. ↑ "5'-terminal structures of poly(A)+ cytoplasmic messenger RNA and of poly(A)+ and poly(A)- heterogeneous nuclear RNA of cells of the dipteran Drosophila melanogaster". Journal of Molecular Biology 120 (4): 487–515. April 1978. doi:10.1016/0022-2836(78)90350-9. PMID 418182. 
  11. ↑ "In maize poly(A)-containing RNA". Plant Science Letters 15 (4): 357–361. 1979. doi:10.1016/0304-4211(79)90141-X. 
  12. ↑ "Wheat embryo ribonucleates. XIII. Methyl-substituted nucleoside constituents and 5'-terminal dinucleotide sequences in bulk poly(AR)-rich RNA from imbibing wheat embryos". Canadian Journal of Biochemistry 57 (6): 927–931. June 1979. doi:10.1139/o79-112. PMID 476526. 
  13. ↑ "MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor". The Plant Cell 20 (5): 1278–1288. May 2008. doi:10.1105/tpc.108.058883. PMID 18505803. 
  14. ↑ 14.0 14.1 "Induction of sporulation in Saccharomyces cerevisiae leads to the formation of N6-methyladenosine in mRNA: a potential mechanism for the activity of the IME4 gene". Nucleic Acids Research 30 (20): 4509–4518. October 2002. doi:10.1093/nar/gkf573. PMID 12384598. 
  15. ↑ 15.0 15.1 15.2 "Yeast targets for mRNA methylation". Nucleic Acids Research 38 (16): 5327–5335. September 2010. doi:10.1093/nar/gkq266. PMID 20421205. 
  16. ↑ 16.0 16.1 16.2 16.3 16.4 16.5 "Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons". Cell 149 (7): 1635–1646. June 2012. doi:10.1016/j.cell.2012.05.003. PMID 22608085. 
  17. ↑ 17.0 17.1 17.2 17.3 17.4 "Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq". Nature 485 (7397): 201–206. April 2012. doi:10.1038/nature11112. PMID 22575960. Bibcode: 2012Natur.485..201D. 
  18. ↑ "Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase". RNA 3 (11): 1233–1247. November 1997. PMID 9409616. 
  19. ↑ "Sequence specificity of the human mRNA N6-adenosine methylase in vitro". Nucleic Acids Research 18 (19): 5735–5741. October 1990. doi:10.1093/nar/18.19.5735. PMID 2216767. 
  20. ↑ "Precise localization of m6A in Rous sarcoma virus RNA reveals clustering of methylation sites: implications for RNA processing". Molecular and Cellular Biology 5 (9): 2298–2306. September 1985. doi:10.1128/mcb.5.9.2298. PMID 3016525. 
  21. ↑ "Mapping of N6-methyladenosine residues in bovine prolactin mRNA". Proceedings of the National Academy of Sciences of the United States of America 81 (18): 5667–5671. September 1984. doi:10.1073/pnas.81.18.5667. PMID 6592581. Bibcode: 1984PNAS...81.5667H. 
  22. ↑ 22.0 22.1 "A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation". Nature Chemical Biology 10 (2): 93–95. February 2014. doi:10.1038/nchembio.1432. PMID 24316715. 
  23. ↑ "N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells". Nature Cell Biology 16 (2): 191–198. February 2014. doi:10.1038/ncb2902. PMID 24394384. 
  24. ↑ "Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase". Cell Research 24 (2): 177–189. February 2014. doi:10.1038/cr.2014.3. PMID 24407421. 
  25. ↑ "Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites". Cell Reports 8 (1): 284–296. July 2014. doi:10.1016/j.celrep.2014.05.048. PMID 24981863. 
  26. ↑ "The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112". Nucleic Acids Research 47 (15): 7719–7733. September 2019. doi:10.1093/nar/gkz619. PMID 31328227. 
  27. ↑ "Grand challenge commentary: RNA epigenetics?". Nature Chemical Biology 6 (12): 863–865. December 2010. doi:10.1038/nchembio.482. PMID 21079590. 
  28. ↑ "N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO". Nature Chemical Biology 7 (12): 885–887. October 2011. doi:10.1038/nchembio.687. PMID 22002720. 
  29. ↑ "ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility". Molecular Cell 49 (1): 18–29. January 2013. doi:10.1016/j.molcel.2012.10.015. PMID 23177736. 
  30. ↑ "N6-methyladenosine-dependent regulation of messenger RNA stability". Nature 505 (7481): 117–120. January 2014. doi:10.1038/nature12730. PMID 24284625. Bibcode: 2014Natur.505..117W. 
  31. ↑ "N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency". Cell 161 (6): 1388–1399. June 2015. doi:10.1016/j.cell.2015.05.014. PMID 26046440. 
  32. ↑ "Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain". Nature Chemical Biology 10 (11): 927–929. November 2014. doi:10.1038/nchembio.1654. PMID 25242552. 
  33. ↑ "Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing". Molecular Cell 61 (4): 507–519. February 2016. doi:10.1016/j.molcel.2016.01.012. PMID 26876937. 
  34. ↑ 34.0 34.1 34.2 "Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation". Nature Cell Biology 20 (3): 285–295. March 2018. doi:10.1038/s41556-018-0045-z. PMID 29476152. 
  35. ↑ "N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions". Nature 518 (7540): 560–564. February 2015. doi:10.1038/nature14234. PMID 25719671. Bibcode: 2015Natur.518..560L. 
  36. ↑ "Exon architecture controls mRNA m6A suppression and gene expression". Science 379 (6633): 677–682. February 2023. doi:10.1126/science.abj9090. PMID 36705538. 
  37. ↑ 37.0 37.1 "Adenosine Methylation in Arabidopsis mRNA is Associated with the 3' End and Reduced Levels Cause Developmental Defects". Frontiers in Plant Science 3: 48. 2012. doi:10.3389/fpls.2012.00048. PMID 22639649. 
  38. ↑ 38.0 38.1 "RMBase: a resource for decoding the landscape of RNA modifications from high-throughput sequencing data". Nucleic Acids Research 44 (D1): D259–D265. January 2016. doi:10.1093/nar/gkv1036. PMID 26464443. 
  39. ↑ 39.0 39.1 39.2 39.3 "A majority of m6A residues are in the last exons, allowing the potential for 3' UTR regulation". Genes & Development 29 (19): 2037–2053. October 2015. doi:10.1101/gad.269415.115. PMID 26404942. 
  40. ↑ "m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover". Genes & Development 31 (10): 990–1006. May 2017. doi:10.1101/gad.301036.117. PMID 28637692. 
  41. ↑ "Settling the m6A debate: methylation of mature mRNA is not dynamic but accelerates turnover". Genes & Development 31 (10): 957–958. May 2017. doi:10.1101/gad.302695.117. PMID 28637691. 
  42. ↑ "FTO mediates LINE1 m6A demethylation and chromatin regulation in mESCs and mouse development". Science 376 (6596): 968–973. May 2022. doi:10.1126/science.abe9582. PMID 35511947. 
  43. ↑ "N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells". Nature Genetics 52 (1): 48–55. January 2020. doi:10.1038/s41588-019-0549-x. PMID 31844323. 
  44. ↑ "RNA-methylation-dependent RNA processing controls the speed of the circadian clock". Cell 155 (4): 793–806. November 2013. doi:10.1016/j.cell.2013.10.026. PMID 24209618. 
  45. ↑ "m(6)A mRNA methylation: a new circadian pacesetter". Cell 155 (4): 740–741. November 2013. doi:10.1016/j.cell.2013.10.028. PMID 24209613. 
  46. ↑ "Methylation deficiency disrupts biological rhythms from bacteria to humans". Communications Biology 3 (1): 211. May 2020. doi:10.1038/s42003-020-0942-0. PMID 32376902. 
  47. ↑ "Genetic profile and determinants of homocysteine levels in Kazakhstan patients with breast cancer". Anticancer Research 33 (9): 4049–4059. September 2013. PMID 24023349. 
  48. ↑ "Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer". British Journal of Cancer 109 (4): 872–881. August 2013. doi:10.1038/bjc.2013.441. PMID 23922112. 
  49. ↑ "Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice". Endocrine-Related Cancer 19 (3): 409–421. June 2012. doi:10.1530/ERC-11-0387. PMID 22454401. 
  50. ↑ "Biochemical function of female-lethal (2)D/Wilms' tumor suppressor-1-associated proteins in alternative pre-mRNA splicing". The Journal of Biological Chemistry 278 (5): 3040–3047. January 2003. doi:10.1074/jbc.M210737200. PMID 12444081. 
  51. ↑ "Expression and roles of Wilms' tumor 1-associating protein in glioblastoma". Cancer Science 103 (12): 2102–2109. December 2012. doi:10.1111/cas.12022. PMID 22957919. 
  52. ↑ "Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan". BMC Cancer 13: 337. July 2013. doi:10.1186/1471-2407-13-337. PMID 23835106. 
  53. ↑ "Wilms' tumor 1 as a novel target for immunotherapy of leukemia". Transplantation Proceedings 42 (8): 3309–3311. October 2010. doi:10.1016/j.transproceed.2010.07.034. PMID 20970678. 
  54. ↑ "Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO)". Journal of Biomedicine & Biotechnology 2010: 841451. 2010-03-18. doi:10.1155/2010/841451. PMID 20339516. 
  55. ↑ "Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium". American Journal of Epidemiology 176 (12): 1121–1129. December 2012. doi:10.1093/aje/kws191. PMID 23193118. 
  56. ↑ "Evaluating genome-wide association study-identified breast cancer risk variants in African-American women". PLOS ONE 8 (4): e58350. 2013-04-08. doi:10.1371/journal.pone.0058350. PMID 23593120. Bibcode: 2013PLoSO...858350L. 
  57. ↑ "The role of the fat mass and obesity associated gene (FTO) in breast cancer risk". BMC Medical Genetics 12: 52. April 2011. doi:10.1186/1471-2350-12-52. PMID 21489227. 
  58. ↑ "Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data". Cancer Causes & Control 22 (6): 877–883. June 2011. doi:10.1007/s10552-011-9760-5. PMID 21445555. 
  59. ↑ "The biosynthesis and functional roles of methylated nucleosides in eukaryotic mRNA". Fine-Tuning of RNA Functions by Modification and Editing. Topics in Current Genetics. 12. Springer Berlin Heidelberg. 2005-01-01. pp. 141–177. doi:10.1007/b106365. ISBN 9783540244950. 
  60. ↑ "The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells". Molecular Cell 62 (3): 335–345. May 2016. doi:10.1016/j.molcel.2016.03.021. PMID 27117702. 
  61. ↑ "Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA". Proceedings of the National Academy of Sciences of the United States of America 113 (14): E2047–E2056. April 2016. doi:10.1073/pnas.1602883113. PMID 27001847. Bibcode: 2016PNAS..113E2047Z. 
  62. ↑ "The bigger picture of FTO: the first GWAS-identified obesity gene". Nature Reviews. Endocrinology 10 (1): 51–61. January 2014. doi:10.1038/nrendo.2013.227. PMID 24247219. 
  63. ↑ "A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity". Science 316 (5826): 889–894. May 2007. doi:10.1126/science.1141634. PMID 17434869. Bibcode: 2007Sci...316..889F. 
  64. ↑ "Variant rs1421085 in the FTO gene contribute childhood obesity in Chinese children aged 3-6 years". Obesity Research & Clinical Practice 7 (1): e14–e22. 2013. doi:10.1016/j.orcp.2011.12.007. PMID 24331679. 
  65. ↑ "Polymorphisms in FTO and near TMEM18 associate with type 2 diabetes and predispose to younger age at diagnosis of diabetes". Gene 527 (2): 462–468. September 2013. doi:10.1016/j.gene.2013.06.079. PMID 23860325. 
  66. ↑ "A link between FTO, ghrelin, and impaired brain food-cue responsivity". The Journal of Clinical Investigation 123 (8): 3539–3551. August 2013. doi:10.1172/jci44403. PMID 23867619. 
  67. ↑ "FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis". Cell Research 24 (12): 1403–1419. December 2014. doi:10.1038/cr.2014.151. PMID 25412662. 
  68. ↑ "FTO influences adipogenesis by regulating mitotic clonal expansion". Nature Communications 6: 6792. April 2015. doi:10.1038/ncomms7792. PMID 25881961. Bibcode: 2015NatCo...6.6792M. 
  69. ↑ "The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation". PLOS ONE 10 (7): e0133788. 2015-07-28. doi:10.1371/journal.pone.0133788. PMID 26218273. Bibcode: 2015PLoSO..1033788Z. 
  70. ↑ "The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry". Nature Neuroscience 16 (8): 1042–1048. August 2013. doi:10.1038/nn.3449. PMID 23817550. 
  71. ↑ "Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS". Nature 495 (7442): 467–473. March 2013. doi:10.1038/nature11922. PMID 23455423. Bibcode: 2013Natur.495..467K. 
  72. ↑ "Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers". Cell Reports 22 (1): 286–298. January 2018. doi:10.1016/j.celrep.2017.12.035. PMID 29298429. 
  73. ↑ "Methylation of mRNA". Advances in Enzymology and Related Areas of Molecular Biology. 65. 1992. pp. 255–285. doi:10.1002/9780470123119.ch7. ISBN 9780470123119. 
  74. ↑ "Posttranscriptional m(6)A Editing of HIV-1 mRNAs Enhances Viral Gene Expression". Cell Host & Microbe 19 (5): 675–685. May 2016. doi:10.1016/j.chom.2016.04.002. PMID 27117054. 
  75. ↑ "N(6)-methyladenosine of HIV-1 RNA regulates viral infection and HIV-1 Gag protein expression". eLife 5. July 2016. doi:10.7554/eLife.15528. PMID 27371828. 
  76. ↑ "Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells". Nature Microbiology 1 (4): 16011. February 2016. doi:10.1038/nmicrobiol.2016.11. PMID 27572442. 
  77. ↑ "Dynamics of Human and Viral RNA Methylation during Zika Virus Infection". Cell Host & Microbe 20 (5): 666–673. November 2016. doi:10.1016/j.chom.2016.10.002. PMID 27773536. 
  78. ↑ "N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection". Cell Host & Microbe 20 (5): 654–665. November 2016. doi:10.1016/j.chom.2016.09.015. PMID 27773535. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:N6-Methyladenosine&oldid=3422977"